Insider · CIK 0001694466
MACK DAVID J.
Reports to the SEC for 4 companies · NEW YORK, NY
Transactions
32
Companies
4
Filings
11
CIK
0001694466
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-01-09 | BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-10-31 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-10-31 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-09-30 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-09-30 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-08-31 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-08-31 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-07-31 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-07-31 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-06-30 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-06-30 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-05-31 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-05-31 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-04-30 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-04-30 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-03-31 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-03-31 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-02-28 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-02-28 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-01-31 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2025-01-31 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-12-31 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2024-12-31 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-11-30 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2024-11-30 | BTAIBioXcel Therapeutics, Inc.M Exercise/Conversion | — |
| 2024-11-30 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-11-21 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsA Award | — |
| 2024-11-21 | BTAIBioXcel Therapeutics, Inc. · Restricted Stock UnitsA Award | — |
| 2017-12-28 | TERRAFORM GLOBAL, INC.Restricted Stock Units (Class A common stock)D Disposition to Issuer | −$283K |
| 2017-12-28 | TERRAFORM GLOBAL, INC.Restricted Stock Units (Class A common stock)J Other | — |
| 2017-08-04 | TERRAFORM GLOBAL, INC.Restricted Stock Units (Class A common stock)A Award | — |
| 2017-01-04 | TERRAFORM GLOBAL, INC.Restricted Stock Units (Class A common stock)A Award | — |
Recent filings
- 4MACK DAVID J.0001104659-26-002973SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-105760SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-095739SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-086528SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-072701SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-064148SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-055610SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-043628SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-030679SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-020519SEC(opens sec.gov)
- 4MACK DAVID J.0001104659-25-009204SEC(opens sec.gov)
Companies
Address
410 PARK AVENUE, SUITE 900
NEW YORK, NY, 10022